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increased immediately after BPA. Both MLD-b and MLD-d further increased at chronic
phase (figure).
Conclusions: BPA achieves beneficial vascular remodeling at distal segment as well as
ballooning site, which is associated with chronic improvement in pulmonary artery
resistance.
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Background: Acute deep venous thrombosis (DVT) responds favorably to various
thrombectomy devices including Trellis (Covidien). In patients with an IVC filter,
occasionally massive bilateral DVT may occur with frequent involvement of the filter.
The role of Trellis in the treatment of IVC filter thrombosis (IVCFT) has not been
investigated.
Methods: Fifty two patients with IVCFT underwent treatment with Trellis as part of the
percutaneous endovenous intervention (PEVI) strategy(Fig.1). All had bilateral lower
extremity and iliac DVT and were quite symptomatic. For initial treatment an 8 F Trellis
system was used in all with administration of 10 mg of tPA via the Trellis catheter. The
device was activated inside the filter.Following the procedure venography was obtained to
assess the outcome.
Results: No patient achieved complete resolution of IVCFT with Trellis thrombectomy
alone. Partial resolution was achieved in only 8 patients. The remaining 44 patients had
no meaningful improvement and required catheter-directed thrombolysis (CDT) with tPA
for a mean duration of 328 hours. With CDT complete or substantial resolution of
IVCFT was achieved. There was no symptomatic pulmonary embolism as a result of
PEVI.
Conclusions: IVCFT is associated with bilateral iliac and femoropopliteal DVT. Trellis
thrombectomy alone has a limited role in its management and most patients require CDT.
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Background: Acute pulmonary embolism (PE) is a potentially fatal condition. Recent
studies demonstrate support for advanced treatment, especially in patients who present
with systemic hypotension (massive PE) and those who are normotensive but show signs
of RV dysfunction (submassive PE), leading to poor outcomes if inadequately treated.
This study assesses the hemodynamic effects of ultrasound accelerated thrombolysis
(USAT), an emerging catheter-based modality, among these patients in resolving the
thrombus and restoring cardiopulmonary function.
Methods: We retrospectively evaluated consecutive PE patients treated using USAT
(EkoSonic Endovascular System, EKOS Corporation) with recombinant tPA at East
Jefferson General Hospital from 2009 to 2011. All patients presented with signs of acute
PE and received chest CT scans for confirmation of PE. Follow-up CT was performed at
3923 hours after USAT. RV dysfunction was characterized by the right-to-left
ventricular dimension (RV/LV) ratio. Thrombus burden was assessed using the modified
Miller Score. All CT measurements were performed by an independent core laboratory.
Results: Among the 42 patients (age 5816 yrs) evaluated, 7 were massive and 35 were
submassive PE cases. 37 patients (88%) presented with bilateral PE. Overall, the mean
tPA dose was 31.016.6 mg infused over 19.06.8 hours. Following USAT, the RV/LV
ratio was reduced from 1.480.42 to 0.960.18 (p.001) and the modified Miller Score
from 18.05.1 to 9.75.3 (p.001) at follow-up CT. Patients treated early in the series
(n13) using a total dose of45 mg tPA did not show greater reduction in RV/LV ratio
or Miller Score than those later in the series (n29) using a total dose of 20 mg tPA
(p.38). Median length of stay was 1 day in the ICU and 7 days in the hospital. All
patients were discharged alive. There were no systemic bleeding complications, but 4
access site bleeding complications requiring transfusion and 1 suspected recurrent
massive PE event, all reported in the higher tPA dose group.
Conclusions: For massive and submassive PE, treatment by USAT rapidly reduced RV
dilatation and pulmonary clot burden with minimal risk of bleeding, allowing restoration
of cardiopulmonary function.
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Background: Acute high risk pulmonary embolism carries a high degree of morbidity/
mortality and proper and rapid actions must be taken, this study aims to demonstrate how
to recover the patency of the pulmonary arteries by thrombus aspiration with right
coronary guide catheter in order to improve the function of the right ventricle and reduce
mortality.
Methods: A total of 38 patients, 20 female, 18 male, ages 28 to 64 years with high risk
acute pulmonary embolism were studied from March 2009 to April 2012. In all patients
the pulmonary obstruction was bilateral, the degree of obstruction was greater than 80%
of the main branches. The diagnosis was formulated with pulmonary angiotomography
echocardiogram. By percutaneous puncture of the femoral vein an 8 French by 80cm in
length metal sheath was advanced to the trunk of the pulmonary artery, a #4 Judkins right
coronary guide catheter was advanced trough the introducer to the site of thrombosis and
a 20ml syringe connected and vacuum sustained trough the catheter while slowly
withdrawing it, subsequently the catheter was extracted and purged to extract the aspirated
thrombi. This maneuver was repeated several times and finally angiography with this
catheter was perform to confirm the patency of the pulmonary branches.
Results: Extraction of thrombus was achieved in all cases. permeability of the pulmonary
branches was obtained in 80% of the cases, saturation and blood pressure were restored
in the next few hours. One patient (2.63%) died during the procedure and another patient
had hemoptysis.
Conclusions: This is an effective technique for the treatment of high-risk acute
pulmonary embolism reproducible at low-cost and capable to reestablish blood pressure,
oxygen saturation and right ventricular function and decrease morbidity significantly.
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Background: Acute pulmonary embolism (PE) is a major cause of death. 90-day
mortality rates are 58% for massive PE (with cardiogenic shock) and 22% for submassive
PE (right heart strain without shock). Systemic thrombolysis improves hemodynamic
stability but is associated with major bleeding in 20% of patients. Alternative therapies for
acute PE are needed. This study examines the safety and effectiveness of catheter-directed,
ultrasound-accelerated thrombolysis (USAT) in patients with PE.
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